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Kenny-Caffey syndrome (KCS) is characterized by pro-
portionate short stature, cortical thickening and medul-
lary stenosis of tubular bones, delayed closure of anterior
fontanelle, eye abnormalities, and hypoparathyroidism.
The autosomal dominant form (KCS Type 2) caused by
mutations in FAM111A is distinguished from the autoso-
mal recessive form (KCS Type1), caused by mutations in
TBCE gene, by the absence of mental retardation.
Our proband presented on day 8 of life with hypocal-
caemic seizures secondary to hypoparathyroidism. Nor-
mocalcaemia was achieved with IV calcium gluconate
and maintained by oral calcium carbonate 100mg BD
and calcitriol 0.1mcg BD for the first 2 years of life while
serum PTH remained low at <0.3pmol/L. There has been
no evidence of nephrocalcinosis on follow up. The dose
of supplemental calcium and calcitriol is being gradually
reduced. She also has persistent mild microcytic anaemia
with normal iron stores.
Her phenotype included small hands and feet, triangular
hypoplastic and dystrophic nails, hypoplastic mid-face,
macrocrania and large persistent fontanelles. Karotype and
FISH for 22q11 deletion were normal. Initial investigations
included a normal ECHO, renal ultrasound and MRI
brain.
Her neurodevelopment is normal but her growth is
compromised. At 1 year, her length was 65.5cms (SDS
-2.9) and at 3 years, her height was 80cms (SDS -3.8).
There is no family history of short stature or hypopar-
athyroidism. She is growth hormone sufficient on phar-
macological testing; however she has been commenced
on growth hormone treatment based on her poor
growth velocity and short stature. It is currently too
early to determine response.
A skeletal survey performed at 2 years of age was sug-
gestive of KCS. Genetic testing revealed a heterozygous
mutation c.1622C>A (p.Ser541Tyr) in FAM111A. How-
ever, the unusual nails, the reducing calcium require-
ment and the unexplained microcytic anaemia are
unique to our patient.
Written informed Consent for this patient has been
taken including results of the genetic analyses and
images according to the Institutional Ethics Committee
procedures of our health service.
Authors’ details
1Department of Endocrinology, Princess Margaret Hospital, Perth, WA,
Australia. 2Center for Applied Genomics, Abramson Research Center, The
Children’s Hospital of Philadelphia, USA. 3School of Paediatrics and Child
Health, UWA, Perth, WA, Australia. 4Genetic Services of Western Australia,
Princess Margaret Hospital & King Edward Memorial Hospital, Perth, WA,
Australia. 5Division of Human Genetics and Department of Pediatrics, The
Children’s Hospital of Philadelphia and The Perelman School of Medicine,
USA. 6Division of Pulmonary Medicine, The Children’s Hospital of
Philadelphia, USA. 7Division of Endocrinology and Diabetes, The Children’s
Hospital of Philadelphia, USA. 8Center for Bone Health, The Children’s
Hospital of Philadelphia, USA.
Published: 28 April 2015
doi:10.1186/1687-9856-2015-S1-P72
Cite this article as: Abraham et al.: Autosomal dominant Kenny-Caffey
syndrome with congenital hypoparathyroidism, short stature and
normal intellect: a case report. International Journal of Pediatric
Endocrinology 2015 2015(Suppl 1):P72.
1Department of Endocrinology, Princess Margaret Hospital, Perth, WA,
Australia
Full list of author information is available at the end of the article
Abraham et al. International Journal of Pediatric Endocrinology 2015, 2015(Suppl 1):P72
http://www.ijpeonline.com/content/2015/S1/P72
© 2015 Abraham et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
